SG Fleet beats broker forecasts

Published 14-AUG-2018 12:55 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Name: SG Fleet Group Limited (ASX:SGF)

Market Capitalisation: $900 million

Opening Share Price: $3.40

SG Fleet Group (ASX:SGF) has reported a fiscal 2018 profit of $67.7 million, up 13.6% on 2017.

This represented earnings per share of 26.4 cents, placing the company on a trailing price-earnings (PE) multiple of 12.9, a discount to the sector average of 17.

Management declared a final dividend of 9.95 cents per share, bringing the total dividend to 18.7 cents per share, up 11.5% on 2017.

The profit beat Bell Potter’s projections with the broker forecasting a net profit of $66 million.

The result was struck on revenue of $316.5 million, up 7.9% on the previous financial year.

Salary packaging and vehicle leasing

SG Fleet is a leading international mobility solutions provider with operations in Australia, New Zealand and the UK.

The company specialises in fleet management and leasing, as well as salary packaging services.

Growth in both profit and revenue was higher than fleet growth as a result of increased penetration of the company’s add-on products and services within its customer base and higher end of lease income.

One of the key features was the strong full year contribution from the UK business acquired in fiscal 2017.

The economic climate in the UK saw some improvement during the year and this was reflected in an uptick in interest in both tool-of-trade, particularly light commercials, and salary packaging services.

Growth in the current financial year is expected to come primarily from ongoing activities, supplemented by further product and services expansion.

Management noted that many of the products already brought to market are only in the early stages of adoption, and the take-up is now accelerating.

The group also highlighted that it had the head room for acquisitions should opportunities arise.

Note that any decision with regards to adding this stock to your portfolio should be taken with caution and professional financial advice sought.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free